Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-31 @ 9:59 AM
Study NCT ID:
NCT05806268
Status:
COMPLETED
Last Update Posted:
2023-04-10
First Post:
2023-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Patient Characteristics, Associated Factors, and Clinical Outcomes of Prescribing Encorafenib and Binimetenib Versus Dabrafenib and Trametinib Among BRAF v600 Mutated Metastatic Melanoma Patients
Sponsor:
Novartis Pharmaceuticals
Organization: